Phreesia (PHR) Stock Forecast, Price & News

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Phreesia in the last twelve months. There are currently 2 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PHR shares.
View PHR analyst ratings or view top-rated stocks.

13 brokerages have issued 1 year price targets for Phreesia's stock. Their PHR share price forecasts range from $29.00 to $43.00. On average, they anticipate the company's stock price to reach $37.15 in the next year. This suggests a possible upside of 98.9% from the stock's current price.
View analysts price targets for PHR or view top-rated stocks among Wall Street analysts.

Phreesia's stock was trading at $32.36 on January 1st, 2023. Since then, PHR shares have decreased by 42.3% and is now trading at $18.68.
View the best growth stocks for 2023 here.

Phreesia saw a decrease in short interest in the month of September. As of September 15th, there was short interest totaling 1,730,000 shares, a decrease of 15.2% from the August 31st total of 2,040,000 shares. Based on an average daily volume of 410,800 shares, the short-interest ratio is presently 4.2 days.
View Phreesia's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, December 14th 2023.
View our PHR earnings forecast.

Phreesia, Inc. (NYSE:PHR) released its quarterly earnings data on Wednesday, September, 6th. The company reported ($0.68) EPS for the quarter, beating the consensus estimate of ($0.71) by $0.03. The firm had revenue of $85.80 million for the quarter, compared to analysts' expectations of $85.26 million. Phreesia had a negative trailing twelve-month return on equity of 54.52% and a negative net margin of 47.75%. Phreesia's revenue for the quarter was up 26.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.89) earnings per share.

ETFs with the largest weight of Phreesia (NYSE:PHR) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), Fidelity Disruptive Medicine ETF (FMED) and iShares U.S. Healthcare Providers ETF (IHF) and

Phreesia issued an update on its FY 2025 earnings guidance on Wednesday, September, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $500.00 million-$500.00 million, compared to the consensus revenue estimate of $453.67 million.

172 employees have rated Phreesia Chief Executive Officer Chaim Indig on Glassdoor.com. Chaim Indig has an approval rating of 73% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Phreesia investors own include Fastly (FSLY), Zscaler (ZS), Okta (OKTA), DocuSign (DOCU), HealthEquity (HQY), Block (SQ), Appian (APPN), Walt Disney (DIS), Globant (GLOB) and Invitae (NVTA).

(PHR) raised $127 million in an initial public offering (IPO) on Thursday, July 18th 2019. The company issued 7,800,000 shares at $15.00-$17.62 per share. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray acted as the underwriters for the IPO.

Phreesia trades on the New York Stock Exchange (NYSE) under the ticker symbol "PHR."

Shares of PHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PHR stock can currently be purchased for approximately $18.68.

Phreesia (NYSE:PHR) has a market capitalization of $1.03 billion and generates $280.91 million in revenue each year. The company earns $-176,150,000.00 in net income (profit) each year or ($2.86) on an earnings per share basis.

The company employs 1,546 workers across the globe.

Phreesia's mailing address is 432 Park Avenue South 12th Floor, New York NY, 10016. The official website for the company is www.phreesia.com. The company can be reached via phone at (888) 654-7473, via email at investors@phreesia.com, or via fax at 646-607-1776.